2nd Quarter - Report

SQUIRE PATTON BOGGS for BRISTOL-MYERS SQUIBB COMPANY

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare Prescription Drug Savings and Choice Act (S. 333/H.R. 684); Medicaid Prescription Drug Rebate Equalization Act of 2009 (HR 904); Drug Rebate Equalization Act of 2009 (S 547) Voluntary State Discount Prescription Drug Plan Act of 2009 (HR 1725)

LobbyistCovered position, as disclosed
THOMAS HALE BOGGS —
JOHN JONAS —
MARTHA KENDRICK —
KAREN THIEL —
MATTHEW TODD TUTEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 684 (111th), S. 333 (111th), H.R. 1725 (111th), H.R. 904 (111th)

Health Issues HCR

American Recovery and Reinvestment Act (PL 111-5); Promoting Innovation and Access to Life-Saving Medicine Act (HR 1427/S 726); Pathway for Biosimilars Act (HR 1548); Patient-Centered Outcomes Research Act of 2009 (S1213); Comparative Effectiveness Research Act of 2009 (HR 2502); Doctor-Patient Relationship and Research Protection Act (HR 2824); Protecting Consumer Access to Generic Drugs Act of 2009 (HR 1706); Food and Drug Administration Globalization Act of 2009 (HR 759); Drug and Device Accountability Act of 2009 (S 882) Pharmaceutical Market Access and Drug Safety Act of 2009 (HR 1298/S 1232)

LobbyistCovered position, as disclosed
THOMAS HALE BOGGS —
JOHN JONAS —
MARTHA KENDRICK —
KAREN THIEL —
MATTHEW TODD TUTEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2502 (111th), H.R. 1706 (111th), H.R. 759 (111th), H.R. 1548 (111th), H.R. 1427 (111th), H.R. 1298 (111th), H.R. 2824 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.